39 patents currently held
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jul 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
5
Ending by 2030
Jul 2027
Next term end
37
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jul 2027 · High confidence
Also notable
Ends Jan 2039 · High confidence
Also notable
Ends Feb 2033 · High confidence
Topical compositions associating sodium hyaluronate fragments and retinoid useful for cosmetic and medical dermatology
US 8,968,751
Granted 2015 and renewed at every maintenance window due so far. Protection runs to 2027.
Bacterial Secretome for Use in the Treatment of Skin Lesions
US 11,484,555
The newest of the three, granted 2022. It anchors the portfolio to 2039, later than anything else here.
Novel Photoprotective System
US 9,763,867
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2033.
Formerly held, still cited
Notable
Ends Dec 2031 · High confidence
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2031.
now held by Sorbonne Universite
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 28, 2026
- 2 fees due Dec 25 to 27, 2026 · next Dec 25
- 2 fees due Jan 4 to 25, 2027 · next Jan 4
- 1 fee due Feb 11, 2027The maintenance fee for Use of 2,3-Dihydroxypropyl Dodecanoate for Treating Seborrhoea (US 9,101,785) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.
- 2 fees due Jul 2 to 14, 2027 · next Jul 2
- 3 fees due Nov 7 to 17, 2027 · next Nov 7
Recent changes
- 1 term has ended since Aug 20, 2026
What they patent
The 5 largest of its 37 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Device and Method for Ultra-High Temperature Sterilization of an Emulsion | 2 in force | to Jan 2033 |
| Extract of Aerial Parts of Oats Harvested Before Ear Emergence | 2 in force | to Nov 2030 |
| Extract of Silybum Marianum (L.) Gaertn. Akenes for Promoting Hair Growth | 1 in force | to May 2043 |
| Lespedeza Capitata Extract for Use in the Field of Hair Care | 1 in force | to Jan 2042 |
| Device for Characterizing and Comparing Erythemal Zones | 1 in force | to Dec 2040 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,968,751 | Topical compositions associating sodium hyaluronate fragments and retinoid useful for cosmetic and medical dermatology In force · High confidence | In force | High confidence | |
| US 8,053,573 | Monomer 5, 6-Diphenyl-1.2.4-Triazinic Derivatives and the Use Thereof In force · High confidence | In force | High confidence | |
| US 10,300,102 | Extract of Aerial Parts of Oats In force · High confidence | In force | High confidence | |
| US 9,339,668 | Extract of Aerial Parts of Oats Harvested Before Ear Emergence In force · High confidence | In force | High confidence | |
| US 9,101,785 | Use of 2,3-Dihydroxypropyl Dodecanoate for Treating Seborrhoea In force · High confidence | In force | High confidence | |
| US 9,486,486 | Novel Bacterium and Extracts of Said Bacterium and the Use of Same in Therapy held by Pierre Fabre Dermo-Cosmetique and Pierre Fabre Medicament In force · Medium confidence | In force | Medium confidence | |
| US 9,566,222 | Peptidyl Arginine Deiminase 1 And/Or 3 Activator Compounds in the Epidermis and Uses Thereof In force · High confidence | In force | High confidence | |
| US 9,562,065 | Sucrose Octasulfates of Magnesium, Preparation Method Thereof and Pharmaceutical Cosmetic Uses of Same In force · High confidence | In force | High confidence | |
| US 10,328,165 | Device and Method for Ultra-High Temperature Sterilization of an Emulsion In force · High confidence | In force | High confidence | |
| US 9,439,987 | Device and Method for Ultra-High Temperature Sterilization of an Emulsion In force · High confidence | In force | High confidence |
Also on record, not counted in the 39: 4 patents in force now held by others · 33 patents ended · 18 applications pending · 39 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.